UK markets closed

Virpax Pharmaceuticals, Inc. (VRPX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.4100-0.0900 (-3.60%)
As of 01:17PM EDT. Market open.
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
9,142
18,995
36,842
54.796
Total cash
9,142
18,995
36,842
54.796
Net receivables
-
-
-
0
Other current assets
67.222
25.341
2,475
0.535
Total current assets
9,628
19,674
39,572
73.069
Non-current assets
Total non-current assets
0
0
0
392.337
Total assets
9,628
19,674
39,572
465.406
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
-
-
543.99
Accrued liabilities
1,694
1,095
2,088
2,074
Other current liabilities
6,000
2,000
-
-
Total current liabilities
7,694
3,095
2,088
3,660
Non-current liabilities
Long-term debt
-
-
-
1,022
Total non-current liabilities
0
0
0
1,022
Total liabilities
7,694
3,095
2,088
4,682
Stockholders' equity
Common stock
0.012
0.012
0.117
0.031
Retained earnings
-59,544
-44,355
-22,704
-10,648
Total stockholders' equity
1,934
16,579
37,485
-4,216
Total liabilities and stockholders' equity
9,628
19,674
39,572
465.406